GenAI adoption is outpacing control. According to Cyera's 2025 State of AI Report, 83% of organizations now use AI in daily work, yet only 13% say they have strong visibility into how it touches ...
Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage ...
Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein innovation, reported results for the fiscal second quarter ended ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback